PHAT
Phathom Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.50
+4.97%Forward multiples
Based on analyst estimates
- P/E forward
- 89.79x
- P/E 2026E
- —
- P/E 2027E
- 9.85x
- P/E 2028E
- 3.91x
- P/S forward
- 1.94x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -2.23x
- Price / sales
- 3.21x
- Price / cash flow
- -20.95x
Enterprise value
- Enterprise value
- $753.2M
- EV / sales
- 3.14x
- EV / EBITDA
- -21.44x
- EV / EBIT
- -18.53x
- Market cap
- $768.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026